Creating a Robust Pricing Compliance/Audit Program That Will Provide the Most Accurate Calculations and the Ability to Verify Them
March 11, 2009
Foley Partner Lena Robins is speaking at the American Conference Institute’s (ACI) 7th Annual Advanced forum on Government Regulation of Prescription Drug Pricing, March 11 – 12, 2009 in New York, New York.
Ms. Robins is speaking on March 11, 2009 at 4:15 p.m. Her session is titled “Creating a Robust Pricing Compliance/Audit Program That Will Provide the Most Accurate Calculations and the Ability to Verify Them.” Topics to be covered include:
- Developing a compliance program that conforms to HHS OIG draft Compliance Program Guidance for the pharmaceutical industry
- Reducing risk in the three areas identified by the OIG as the most problematic:
- integrity of data
- kickbacks and illegal remuneration
- samples
- integrity of data
- Defining the relationship between the government pricing function and the compliance department
- what role does or should the finance department play?
- Weighing the pros and cons of outsourcing calculations
- what can or should be outsourced?
- ensuring that outsources calculations are correct
- what is the government’s position on outsourcing calculations?
Related Insights
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.
June 4, 2025
Energy Current
Nuclear’s Comeback: What Renewables Professionals Should Know
The clean energy transition isn’t a zero-sum game – it’s a team effort. And one player is stepping back into the spotlight with renewed…
June 4, 2025
Foley Ignite
M&A Disputes Set to Rise in Latin America: How Savvy Investors Are Protecting Themselves
As deal activity shows signs of rebounding in 2025, investors are bracing for an increase in M&A-related disputes globally, and Latin…